Home » Topics » Disease categories and therapies » Inflammatory

Inflammatory
RSS

Elderly cells found in regenerating organs

June 13, 2019

Bacteriophages have "cascading effects" on microbiome

June 12, 2019

Principia Biopharma patents proteasome subunit beta type-8 and/or beta type-9 inhibitors

June 7, 2019

Senju Pharmaceutical synthesizes new PAC1 and/or VPAC1 and/or VPAC2 receptor ligands

June 6, 2019

CCR5 mutation leads to increased mortality

June 4, 2019

FOX-115 improves endurance of motor performances in aged mice

May 20, 2019

Vasopressin V2 receptor antagonists disclosed by Toa Eiyo

May 17, 2019

Boehringer Ingelheim identifies new Bruton tyrosine kinase inhibitors

May 3, 2019

Bristol-Myers Squibb synthesizes new galectin 3 inhibitors

April 30, 2019

Nihon Pharmaceutical and Niigata University present liver integrated bone marrow-derived stem cells

April 18, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 8, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
Autobahn on the fast track with bipolar thyroid agonist
BioWorld
Achieving high marks in the phase II Amplify-BD trial for bipolar I and II depression, Autobahn Therapeutics Inc.’s elunetirom, a brain-penetrant central nervous...